Drug Markets/Atazanavir

Atazanavir

8 NDCs across 4 manufacturers|6 Generic,2 Brand

Atazanavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Atazanavir is available as 8 NDCs from 4 manufacturers (6 generic, 2 brand), with NADAC prices from $1.11 to $46.99 per EA — the most expensive product costs about 42× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

8

6G / 2B

Manufacturers

4

competing in market

Price Spread

$1.11 – $46.99

per EA

7d Activity

3↓5 flat

avg -3.6% WoW · of 8 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

8 NDCs total, 8 shown

Frequently Asked Questions

What is Atazanavir used to treat?

Atazanavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

How many Atazanavir products are on the market?

The Atazanavir drug market contains 8 NDCs from 4 manufacturers — 6 generic and 2 brand products.

What is the price range for Atazanavir?

NADAC reference prices for Atazanavir range from $1.1087 to $46.9853 per EA — the most expensive product costs about 42× the cheapest.

Is generic Atazanavir cheaper than brand?

The average generic NADAC for Atazanavir is $1.6676 per EA, versus $35.3253 for brand-labeled products — brand versions average about 21× the generic price.

Which manufacturers make Atazanavir?

4 manufacturers list Atazanavir in NADAC. Ranked by number of NDCs, the largest are E.R. Squibb & Sons, L.L.C. (2), Aurobindo Pharma Limited (2), Camber Pharmaceuticals Inc. (2), Laurus Labs Limited (2).

How has the price of Atazanavir changed recently?

Over the past 7 days, 0 Atazanavir NDCs rose and 3 fell, with a market-wide average change of -3.6%.